Issue Date: November 8, 2006
Issued by: Center for Veterinary Medicine
Topic(s): Generic Animal Drugs, Generic Drugs
Status: Final
This document is intended to provide guidance for the design and analysis of in vivo bioequivalence studies.
Download the Guidance Document
Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.
